The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Klema Cathy since year 2005.
The trader's CIK number is 1181157.
At the time of the last reporting, Klema Cathy was the Director of Watson Pharmaceuticals Inc .
(stock ticker symbol WPI).
See this page for all insider trading activities at Watson Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2013-08-12||ACT||Watson Pharmaceuticals Inc||Sale||1,667||133.03||221,766|
|2012-07-31||WPI||Watson Pharmaceuticals Inc||Sale||21,700||78.38||1,700,846|
|2012-07-31||WPI||Watson Pharmaceuticals Inc||Option Ex||21,700||34.43||747,131|
|2008-05-28||PPDI||Pharmaceutical Product Development Inc||Option Ex||8,000||13.58||108,640|
|2008-05-28||PPDI||Pharmaceutical Product Development Inc||Sale||8,000||43.59||348,760|
|2007-05-23||PPDI||Pharmaceutical Product Development Inc||Option Ex||12,000||12.81||153,720|
|2007-05-23||PPDI||Pharmaceutical Product Development Inc||Sale||12,000||35.48||425,700|
|2006-02-27||PPDI||Pharmaceutical Product Development Inc||Sale||4,000||70.09||280,360|
|2006-02-27||PPDI||Pharmaceutical Product Development Inc||Option Ex||4,000||31.64||126,560|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Klema Cathy (Director of Watson Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.